Published in Biotech Business Week, May 4th, 2006
Although the Burrill Mid-Cap Biotech Index dropped almost 5% in March, it still closed out the quarter up 24.5%. Topping this was the Burrill Small-Cap Biotech Index, which was up 2.5% in March and an impressive 26.6% for the first quarter of 2006. This was in stark contrast to the Burrill Biotech Select Index, which was down 4.5% for the month and 0.5% for the quarter. The NASDAQ finished March up 2.5% and a healthy 6% for quarter, and the Dow was also up 1% for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.